Breaking News Instant updates and real-time market news.

KEYUF

Keyera

$26.83 /

-1.0661 (-3.82%)

11:59
06/18/21
06/18
11:59
06/18/21
11:59

Keyera price target raised to C$36 from C$32 at CIBC

CIBC analyst Robert Catellier raised the firm's price target on Keyera to C$36 from C$32 and keeps an Outperformer rating on the shares.

KEYUF Keyera
$26.83 /

-1.0661 (-3.82%)

06/17/21 Credit Suisse
Keyera downgraded to Neutral from Outperform at Credit Suisse
05/31/21 Industrial Alliance
Keyera upgraded to Buy from Hold at Industrial Alliance
05/14/21 Desjardins
Keyera price target raised to C$31 from C$28 at Desjardins
05/13/21 National Bank
Keyera price target raised to C$31 from C$28 at National Bank

TODAY'S FREE FLY STORIES

Recommendations
Roku price target raised to $600 from $560 at DA Davidson » 07:44
08/05/21
08/05
07:44
08/05/21
07:44
ROKU

Roku

$420.63 /

+3.24 (+0.78%)

DA Davidson analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
$420.63 /

+3.24 (+0.78%)

ROKU Roku
$420.63 /

+3.24 (+0.78%)

07:42 Today Benchmark
Benchmark would be buyers of Roku on post-earnings weakness
07:39 Today Stephens
Roku upgraded to Overweight from Equal Weight at Stephens
08/02/21 Morgan Stanley
Roku price target raised to $325 from $300 at Morgan Stanley
07/13/21 KeyBanc
D2C video services best positioned to capture industry economics, says KeyBanc
ROKU Roku
$420.63 /

+3.24 (+0.78%)

ROKU Roku
$420.63 /

+3.24 (+0.78%)

ROKU Roku
$420.63 /

+3.24 (+0.78%)

ROKU Roku
$420.63 /

+3.24 (+0.78%)

Hot Stocks
MultiPlan names Dale White as COO, says CFO David Redmond to retire at year end » 07:44
08/05/21
08/05
07:44
08/05/21
07:44
MPLN

MultiPlan

$7.72 /

-0.045 (-0.58%)

MultiPlan announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

07/07/21 Citi
Citi sees policy change being narrowly applied, keeps Buy on MultiPlan
05/14/21 B. Riley
MultiPlan quarter highlights industry positioning, says B. Riley
04/07/21 B. Riley
B. Riley starts MultiPlan at Buy, sees 'meaningful investment opportunity'
04/06/21 B. Riley
MultiPlan initiated with a Buy at B. Riley
MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

MPLN MultiPlan
$7.72 /

-0.045 (-0.58%)

Earnings
DigitalOcean sees FY21 revenue $419M-$423M, consensus $407.74M » 07:44
08/05/21
08/05
07:44
08/05/21
07:44
DOCN

DigitalOcean

$58.80 /

-2.13 (-3.50%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

07/23/21 Barclays
DigitalOcean price target raised to $64 from $58 at Barclays
04/19/21
Fly Intel: Top five analyst initiations
04/19/21 JPMorgan
DigitalOcean initiated with an Overweight at JPMorgan
04/19/21 Canaccord
Canaccord starts Digital Ocean as cloud adoption continues to accelerate
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

  • 24
    Mar
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

Earnings
NRG Energy reports Q2 EPS $4.40, consensus $1.46 » 07:43
08/05/21
08/05
07:43
08/05/21
07:43
NRG

NRG Energy

$41.74 /

+0.1 (+0.24%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NRG NRG Energy
$41.74 /

+0.1 (+0.24%)

NRG NRG Energy
$41.74 /

+0.1 (+0.24%)

06/27/21 Goldman Sachs
NRG Energy upgraded to Conviction Buy from Buy at Goldman Sachs
06/21/21 Seaport Global
NRG Energy price target raised to $47 from $42 at Seaport Global
03/18/21
Fly Intel: Top five analyst downgrades
03/18/21 Morgan Stanley
NRG Energy price target lowered to $51 from $59 at Morgan Stanley
NRG NRG Energy
$41.74 /

+0.1 (+0.24%)

NRG NRG Energy
$41.74 /

+0.1 (+0.24%)

NRG NRG Energy
$41.74 /

+0.1 (+0.24%)

Earnings
Alico reports Q3 adjusted EPS 51c, one estimate 33c » 07:43
08/05/21
08/05
07:43
08/05/21
07:43
ALCO

Alico

$36.64 /

-0.6 (-1.61%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALCO Alico
$36.64 /

-0.6 (-1.61%)

ALCO Alico
$36.64 /

-0.6 (-1.61%)

12/21/20 Roth Capital
Alico initiated with a Buy at Roth Capital
ALCO Alico
$36.64 /

-0.6 (-1.61%)

Hot Stocks
Intellia Therapeutics expects cash to fund requirements beyond next 24 months » 07:42
08/05/21
08/05
07:42
08/05/21
07:42
NTLA

Intellia Therapeutics

$147.54 /

+8.68 (+6.25%)

Intellia expects that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

06/30/21 Piper Sandler
Poseida Therapeutics being overlooked after Intellia data, says Piper Sandler
06/29/21 Cowen
Alnylam weakness a buying opportunity, says Cowen
06/29/21 Wedbush
Beam Therapeutics price target raised to $149 from $114 at Wedbush
06/29/21 Oppenheimer
Intellia Therapeutics price target raised to $125 from $73 at Oppenheimer
NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

  • 30
    Jun
  • 02
    Dec
NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

Recommendations
Benchmark would be buyers of Roku on post-earnings weakness » 07:42
08/05/21
08/05
07:42
08/05/21
07:42
ROKU

Roku

/

+

Benchmark analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
/

+

ROKU Roku
/

+

07:39 Today Stephens
Roku upgraded to Overweight from Equal Weight at Stephens
08/02/21 Morgan Stanley
Roku price target raised to $325 from $300 at Morgan Stanley
07/13/21 KeyBanc
D2C video services best positioned to capture industry economics, says KeyBanc
07/08/21 Cannonball Research
Roku bear case 'not going to materialize,' says Cannonball Research
ROKU Roku
/

+

ROKU Roku
/

+

ROKU Roku
/

+

ROKU Roku
/

+

Earnings
DigitalOcean sees Q3 revenue $106M-$109M, consensus $104.12M » 07:42
08/05/21
08/05
07:42
08/05/21
07:42
DOCN

DigitalOcean

$58.80 /

-2.13 (-3.50%)

Sees Q3 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

07/23/21 Barclays
DigitalOcean price target raised to $64 from $58 at Barclays
04/19/21
Fly Intel: Top five analyst initiations
04/19/21 JPMorgan
DigitalOcean initiated with an Overweight at JPMorgan
04/19/21 Canaccord
Canaccord starts Digital Ocean as cloud adoption continues to accelerate
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

  • 24
    Mar
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

Downgrade
Nevro downgraded to Equal Weight at Wells Fargo » 07:42
08/05/21
08/05
07:42
08/05/21
07:42
NVRO

Nevro

$147.83 /

-3.47 (-2.29%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

07:22 Today William Blair
Nevro downgraded to Market Perform on uncertainty at William Blair
06:49 Today Canaccord
Nevro downgraded to Hold from Buy at Canaccord
06:10 Today JMP Securities
Nevro price target lowered to $160 from $190 at JMP Securities
06:06 Today Piper Sandler
Nevro downgraded to Neutral from Overweight at Piper Sandler
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

Earnings
Intellia Therapeutics reports Q2 EPS ($1.01), consensus (63c) » 07:42
08/05/21
08/05
07:42
08/05/21
07:42
NTLA

Intellia Therapeutics

$147.54 /

+8.68 (+6.25%)

Reports Q2 revenue $6.6M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

06/30/21 Piper Sandler
Poseida Therapeutics being overlooked after Intellia data, says Piper Sandler
06/29/21 Cowen
Alnylam weakness a buying opportunity, says Cowen
06/29/21 Wedbush
Beam Therapeutics price target raised to $149 from $114 at Wedbush
06/29/21 Oppenheimer
Intellia Therapeutics price target raised to $125 from $73 at Oppenheimer
NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

  • 30
    Jun
  • 02
    Dec
NTLA Intellia Therapeutics
$147.54 /

+8.68 (+6.25%)

Earnings
Madrigal Pharmaceuticals reports Q2 EPS ($3.72), consensus ($3.59) » 07:42
08/05/21
08/05
07:42
08/05/21
07:42
MDGL

Madrigal Pharmaceuticals

$85.02 /

-0.3 (-0.35%)

As of June 30, Madrigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDGL Madrigal Pharmaceuticals
$85.02 /

-0.3 (-0.35%)

MDGL Madrigal Pharmaceuticals
$85.02 /

-0.3 (-0.35%)

07/29/21 BTIG
Viking Therapeutics assumed with a Buy at BTIG
06/25/21 Piper Sandler
Madrigal showed 'compelling improvements' in MAESTRO-NASH, says Piper Sandler
06/23/21 Piper Sandler
Piper 'highly impressed' with Madrigal data in cirrhotic patients
05/24/21 Piper Sandler
Piper says Madrigal's MAESTRO-NASH outcome not impacted by NGM ALPINE data
MDGL Madrigal Pharmaceuticals
$85.02 /

-0.3 (-0.35%)

MDGL Madrigal Pharmaceuticals
$85.02 /

-0.3 (-0.35%)

Downgrade
Fastly downgraded to Neutral from Buy at DA Davidson » 07:41
08/05/21
08/05
07:41
08/05/21
07:41
FSLY

Fastly

$44.50 /

-1.7 (-3.68%)

DA Davidson analyst Rishi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

07:24 Today William Blair
William Blair downgrades Fastly on 'uncertainty and unpredictability'
06:41 Today Citi
Fastly price target lowered to $33 from $46 at Citi
06:09 Today Piper Sandler
Fastly price target lowered to $32 from $45 at Piper Sandler
04:40 Today William Blair
Fastly downgraded to Market Perform from Outperform at William Blair
FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

Hot Stocks
ACI Worldwide announces expanded multi-year strategic alliance with Microsoft » 07:41
08/05/21
08/05
07:41
08/05/21
07:41
ACIW

ACI Worldwide

$32.54 /

-1.02 (-3.04%)

, MSFT

Microsoft

$286.46 /

-0.68 (-0.24%)

ACI Worldwide (ACIW)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

MSFT Microsoft
$286.46 /

-0.68 (-0.24%)

ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

05/06/21 BTIG
ACI Worldwide weakness due to lack of imminent sale signals, says BTIG
02/26/21 BTIG
ACI Worldwide sale 'still appears most likely outcome,' says BTIG
12/09/20 BTIG
ACI Worldwide price target raised to $46 from $39 at BTIG
12/08/20 Craig-Hallum
ACI Worldwide price target raised to $46 from $38 at Craig-Hallum
MSFT Microsoft
$286.46 /

-0.68 (-0.24%)

07/28/21 JPMorgan
Microsoft price target raised to $310 from $300 at JPMorgan
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 BMO Capital
Microsoft price target raised to $325 from $290 at BMO Capital
07/28/21 Wedbush
Wedbush bullish on Microsoft following 'robust' results, guidance
ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

MSFT Microsoft
$286.46 /

-0.68 (-0.24%)

MSFT Microsoft
$286.46 /

-0.68 (-0.24%)

ACIW ACI Worldwide
$32.54 /

-1.02 (-3.04%)

MSFT Microsoft
$286.46 /

-0.68 (-0.24%)

MSFT Microsoft
$286.46 /

-0.68 (-0.24%)

Earnings
DigitalOcean reports Q2 EPS (2c), consensus 5c » 07:41
08/05/21
08/05
07:41
08/05/21
07:41
DOCN

DigitalOcean

$58.80 /

-2.13 (-3.50%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

07/23/21 Barclays
DigitalOcean price target raised to $64 from $58 at Barclays
04/19/21
Fly Intel: Top five analyst initiations
04/19/21 JPMorgan
DigitalOcean initiated with an Overweight at JPMorgan
04/19/21 Canaccord
Canaccord starts Digital Ocean as cloud adoption continues to accelerate
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

  • 24
    Mar
DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

DOCN DigitalOcean
$58.80 /

-2.13 (-3.50%)

Hot Stocks
Wave Life Sciences expects cash to fund requirements into 2Q23 » 07:40
08/05/21
08/05
07:40
08/05/21
07:40
WVE

Wave Life Sciences

$5.60 /

+0.04 (+0.72%)

As of June 30, 2021, Wave…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WVE Wave Life Sciences
$5.60 /

+0.04 (+0.72%)

WVE Wave Life Sciences
$5.60 /

+0.04 (+0.72%)

05/19/21 Mizuho
Wave Life Sciences price target raised to $8 from $7 at Mizuho
03/30/21 Truist
Wave Life Sciences price target lowered to $17 from $27 at Truist
03/30/21 Mizuho
Wave Life Sciences price target lowered to $7 from $21 at Mizuho
03/30/21 RBC Capital
Wave Life Sciences price target lowered to $8 from $13 at RBC Capital
WVE Wave Life Sciences
$5.60 /

+0.04 (+0.72%)

  • 23
    Sep
WVE Wave Life Sciences
$5.60 /

+0.04 (+0.72%)

Hot Stocks
Amicus reaffirms FY21 revenue guidance of $300M-$315M, consensus $308.5M » 07:40
08/05/21
08/05
07:40
08/05/21
07:40
FOLD

Amicus

$9.68 /

+0.34 (+3.64%)

For the full-year 2021,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$9.68 /

+0.34 (+3.64%)

FOLD Amicus
$9.68 /

+0.34 (+3.64%)

07/19/21 BTIG
Amicus assumed with a Buy at BTIG
07/09/21 Chardan
Amicus coverage transferred at Chardan
07/01/21 Berenberg
Amicus assumed with a Hold at Berenberg
05/27/21 Needham
Amicus initiated with a Hold at Needham
FOLD Amicus
$9.68 /

+0.34 (+3.64%)

FOLD Amicus
$9.68 /

+0.34 (+3.64%)

FOLD Amicus
$9.68 /

+0.34 (+3.64%)

Earnings
Wave Life Sciences reports Q2 EPS (78c), consensus (64c) » 07:40
08/05/21
08/05
07:40
08/05/21
07:40
WVE

Wave Life Sciences

$5.60 /

+0.04 (+0.72%)

Reports Q2 revenue $2.77,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WVE Wave Life Sciences
$5.60 /

+0.04 (+0.72%)

WVE Wave Life Sciences
$5.60 /

+0.04 (+0.72%)

05/19/21 Mizuho
Wave Life Sciences price target raised to $8 from $7 at Mizuho
03/30/21 Truist
Wave Life Sciences price target lowered to $17 from $27 at Truist
03/30/21 Mizuho
Wave Life Sciences price target lowered to $7 from $21 at Mizuho
03/30/21 RBC Capital
Wave Life Sciences price target lowered to $8 from $13 at RBC Capital
WVE Wave Life Sciences
$5.60 /

+0.04 (+0.72%)

  • 23
    Sep
WVE Wave Life Sciences
$5.60 /

+0.04 (+0.72%)

Earnings
Xeris Pharmaceuticals reports Q2 EPS (41c), consensus (30c) » 07:39
08/05/21
08/05
07:39
08/05/21
07:39
XERS

Xeris Pharmaceuticals

$2.85 /

-0.105 (-3.55%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XERS Xeris Pharmaceuticals
$2.85 /

-0.105 (-3.55%)

XERS Xeris Pharmaceuticals
$2.85 /

-0.105 (-3.55%)

05/25/21 Craig-Hallum
Strongbridge downgraded to Hold at Craig-Hallum on Xeris acquisition
05/25/21 Mizuho
Xeris Pharmaceuticals price target lowered to $9 from $14 at Mizuho
04/06/21 RBC Capital
Xeris Pharmaceuticals transferred with an Outperform at RBC Capital
08/20/20 Mizuho
Mizuho sees no material impact to Xeris following FDA letter about advertising
XERS Xeris Pharmaceuticals
$2.85 /

-0.105 (-3.55%)

XERS Xeris Pharmaceuticals
$2.85 /

-0.105 (-3.55%)

XERS Xeris Pharmaceuticals
$2.85 /

-0.105 (-3.55%)

Upgrade
Roku upgraded to Overweight from Equal Weight at Stephens » 07:39
08/05/21
08/05
07:39
08/05/21
07:39
ROKU

Roku

$420.63 /

+3.24 (+0.78%)

Stephens analyst Nicholas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
$420.63 /

+3.24 (+0.78%)

ROKU Roku
$420.63 /

+3.24 (+0.78%)

07:35 Today Stephens
Roku upgraded to Overweight from Equal Weight at Stephens
08/02/21 Morgan Stanley
Roku price target raised to $325 from $300 at Morgan Stanley
07/13/21 KeyBanc
D2C video services best positioned to capture industry economics, says KeyBanc
07/08/21 Cannonball Research
Roku bear case 'not going to materialize,' says Cannonball Research
ROKU Roku
$420.63 /

+3.24 (+0.78%)

ROKU Roku
$420.63 /

+3.24 (+0.78%)

ROKU Roku
$420.63 /

+3.24 (+0.78%)

ROKU Roku
$420.63 /

+3.24 (+0.78%)

Recommendations
Bernstein sees several reasons why Musk could step down as Tesla CEO » 07:39
08/05/21
08/05
07:39
08/05/21
07:39
TSLA

Tesla

$710.85 /

+0.99 (+0.14%)

Bernstein analyst Toni…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$710.85 /

+0.99 (+0.14%)

TSLA Tesla
$710.85 /

+0.99 (+0.14%)

08/03/21 Piper Sandler
Piper Sandler still really likes shares of Tesla, keeps $1,200 target
08/02/21 KGI Securities
Tesla initiated with an Outperform at KGI Securities
07/29/21 DZ Bank
Tesla upgraded to Buy from Sell at DZ Bank
07/28/21 Citi
Tesla price target raised to $209 from $175 at Citi
TSLA Tesla
$710.85 /

+0.99 (+0.14%)

TSLA Tesla
$710.85 /

+0.99 (+0.14%)

TSLA Tesla
$710.85 /

+0.99 (+0.14%)

TSLA Tesla
$710.85 /

+0.99 (+0.14%)

Earnings
Brookfield Infrastructure Partners reports Q2 adjusted FFO 85c, consensus 83c » 07:39
08/05/21
08/05
07:39
08/05/21
07:39
BIP

Brookfield Infrastructure Partners

$54.25 /

+0.26 (+0.48%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIP Brookfield Infrastructure Partners
$54.25 /

+0.26 (+0.48%)

BIP Brookfield Infrastructure Partners
$54.25 /

+0.26 (+0.48%)

06/22/21 CIBC
Brookfield Infrastructure Partners resumed with an Outperformer at CIBC
02/11/21 Credit Suisse
Inter Pipeline upgraded to Neutral from Underperform at Credit Suisse
02/11/21 CIBC
Inter Pipeline upgraded to Outperformer from Neutral at CIBC
02/09/21 Barclays
Brookfield Infrastructure Partners price target raised to C$73 at Barclays
BIP Brookfield Infrastructure Partners
$54.25 /

+0.26 (+0.48%)

Earnings
Shyft Group sees FY21 adjusted EPS $1.75-$1.95, consensus $1.80 » 07:38
08/05/21
08/05
07:38
08/05/21
07:38
SHYF

Shyft Group

$38.67 /

-0.46 (-1.18%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHYF Shyft Group
$38.67 /

-0.46 (-1.18%)

SHYF Shyft Group
$38.67 /

-0.46 (-1.18%)

06/08/21 Colliers
California HVIP vouchers 'an important development' for EV stocks, says Colliers
05/26/21 Raymond James
Shyft Group price target raised to $44 from $42 at Raymond James
01/04/21 Colliers
Shyft Group price target raised to $35 from $25 at Colliers
12/17/20 Raymond James
Shyft Group initiated with an Outperform at Raymond James
SHYF Shyft Group
$38.67 /

-0.46 (-1.18%)

SHYF Shyft Group
$38.67 /

-0.46 (-1.18%)

Hot Stocks
Amicus announces upcoming milestones by program » 07:38
08/05/21
08/05
07:38
08/05/21
07:38
FOLD

Amicus

$9.68 /

+0.34 (+3.64%)

Galafold Oral Precision…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$9.68 /

+0.34 (+3.64%)

FOLD Amicus
$9.68 /

+0.34 (+3.64%)

07/19/21 BTIG
Amicus assumed with a Buy at BTIG
07/09/21 Chardan
Amicus coverage transferred at Chardan
07/01/21 Berenberg
Amicus assumed with a Hold at Berenberg
05/27/21 Needham
Amicus initiated with a Hold at Needham
FOLD Amicus
$9.68 /

+0.34 (+3.64%)

FOLD Amicus
$9.68 /

+0.34 (+3.64%)

FOLD Amicus
$9.68 /

+0.34 (+3.64%)

Earnings
Concert Pharmaceuticals reports Q2 EPS 16c, consensus (74c) » 07:38
08/05/21
08/05
07:38
08/05/21
07:38
CNCE

Concert Pharmaceuticals

$3.33 /

+ (+0.00%)

Reports Q2 revenue $32M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNCE Concert Pharmaceuticals
$3.33 /

+ (+0.00%)

CNCE Concert Pharmaceuticals
$3.33 /

+ (+0.00%)

02/02/21 Truist
Concert Pharmaceuticals price target lowered to $22 from $30 at Truist
02/02/21 Mizuho
Concert shares oversold on schizophrenia failure, says Mizuho
02/02/21 H.C. Wainwright
Concert Pharmaceuticals price target lowered to $17 from $25 at H.C. Wainwright
02/01/21 JMP Securities
JMP cuts Concert Pharmaceuticals target but still sees 'compelling upside'
CNCE Concert Pharmaceuticals
$3.33 /

+ (+0.00%)

CNCE Concert Pharmaceuticals
$3.33 /

+ (+0.00%)

CNCE Concert Pharmaceuticals
$3.33 /

+ (+0.00%)

Hot Stocks
Surface Oncology expects cash to fund company through 2023 » 07:37
08/05/21
08/05
07:37
08/05/21
07:37
SURF

Surface Oncology

$5.15 /

-0.69 (-11.82%)

Surface Oncology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SURF Surface Oncology
$5.15 /

-0.69 (-11.82%)

SURF Surface Oncology
$5.15 /

-0.69 (-11.82%)

05/17/21 BTIG
Surface Oncology initiated with a Buy at BTIG
05/17/21 BTIG
Surface Oncology initiated with a Buy at BTIG
03/10/21 Wedbush
Surface Oncology risk/reward 'highly favorable' into data, says Wedbush
12/18/20 H.C. Wainwright
Surface Oncology price target raised to $15 from $11 at H.C. Wainwright
SURF Surface Oncology
$5.15 /

-0.69 (-11.82%)

SURF Surface Oncology
$5.15 /

-0.69 (-11.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.